Drugs with this side effect
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde: 3% - 27.7%
- 5-ASA: 1%
- 5-aza-2'-deoxycytidine: 6.06%
- 5-azacytidine: common, 1.14% - 8.57%
- A77 1726: 3.63% - 4%
- ACTH(1-39: postmarketing, 11%
- Anidulafungin: 4% - 11.5%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- BCNU: 3%
- BPTI
- Bivalirudin: 1% - 6.25%
- CAS 76420-72-9: postmarketing
- CGP 19835A: very common, 26%
- Cancidas: 1.1% - 10%
- Carfilzomib: 0.38% - 14.3%
- Eptifibatide: 0.192%
- FK463: 3% - 6.22%
- FTY720: common, 6%
- Fe(III: postmarketing, 0.4% - 23%
- Forteo: 7.1%
- Gd-DTPA
- Ge-132: 8% - 19%
- Glat copolymer: frequent
- Goserelin: postmarketing, 1-10% - 12%
- Implanon
- Insulin: 3.9% - 5.3%
- K779: postmarketing
- L-Dmp: frequent
- L-threo-DOPS: 1.53% - 7.02%
- LY146032: postmarketing, common, 1.1% - 5.83%
- Lantus: 18.9% - 19.6%
- Leuprorelin: postmarketing, 5% - 8%
- Lovaza
- Lutalyse
- MDV3100: 2.1% - 6.4%
- MK-462
- Meropenem anhydrous
- Metrodin: 0% - 2.7%
- MnDPDP
- Octreotide
- Optison: postmarketing, rare
- PCI-32765
- PGE1: 2% - 39%
- PGE2
- Photofrin: postmarketing, 0% - 6%
- Photofrin II: uncommon
- Protirelin
- Revasc
- S-benzoylmercaptoacetyltriglycine
- SOM230: 9.76% - 10%
- Sativex
- Signifor: 9.76% - 10%
- Stalevo 50
- TR-700
- Terlipressin: postmarketing
- Triptorelin: 0.8% - 14.2%
- UDCA: 8.3%
- VACV: postmarketing, 11% - 38%
- Zyprexa Relprevv
- abiraterone: 0.3% - 3.9%
- acamprosate
- acetaminophen
- acyclovir: postmarketing
- adenosine: postmarketing
- alfentanil: 18%
- allopurinol
- almotriptan: rare
- alosetron
- amantadine
- amifostine
- amisulpride: 0% - 1%
- amitriptyline
- amoxapine
- amphetamine
- amphotericin B: 2.33% - 23.1%
- anagrelide: 1-5%
- anastrozole: 4.94% - 13%
- anthracycline
- aprepitant: 2.1% - 3.2%
- aripiprazole: 2%
- arsenic
- arsenic trioxide
- asenapine: 2% - 3%
- aspirin
- atazanavir: uncommon
- avanafil
- axitinib: 11% - 40%
- azelastine: postmarketing
- azithromycin
- baclofen: uncommon, 0.2% - 2%
- bendamustine
- bepridil
- betamethasone dipropionate
- bexarotene: uncommon, 10%
- bicalutamide: 5%
- bimatoprost: postmarketing, 0.8% - 1.9%
- boceprevir: common
- bortezomib
- bretylium
- brimonidine: very rare
- brinzolamide
- bromocriptine: postmarketing
- budesonide
- bupivacaine: 0.982% - 1.77%
- buprenorphine
- bupropion: postmarketing, 1% - 4.3%
- buspirone: infrequent
- busulfan: 36%
- butorphanol: infrequent
- cabazitaxel
- cabergoline: 5.2%
- cabozantinib: 0% - 33%
- caffeine
- candesartan: postmarketing
- capecitabine: 0.1%
- capsaicin: uncommon, 1% - 2%
- carbamazepine: rare, 3%
- carbidopa
- carboplatin
- carboprost
- carnitine: 18% - 21%
- carvedilol: 0.1% - 2.9%
- cefdinir: postmarketing
- cefpodoxime
- ceftobiprole
- celecoxib: 6.1% - 12.5%
- cetirizine
- cevimeline
- chlorhexidine
- chlorpheniramine
- ciclesonide
- cidofovir
- cilazapril: postmarketing, 1.2%
- cilostazol
- cinacalcet: 7%
- ciprofloxacin: postmarketing
- cisatracurium
- citalopram: infrequent, uncommon, frequent
- clindamycin
- clobetasone butyrate
- clofarabine
- clomiphene citrate: postmarketing
- clomipramine
- clopidogrel
- clozapine: 4% - 12%
- colesevelam: 2.56% - 2.83%
- conivaptan
- copolymer 1
- cortisol
- cortisone
- cosyntropin
- cyclizine
- cyclobenzaprine: postmarketing
- cyclophosphamide: postmarketing
- cysteamine
- cytarabine: 3.57% - 15.2%
- dabigatran etexilate
- dabrafenib
- dalteparin
- danazol
- dantrolene
- dapagliflozin
- darifenacin: uncommon
- darunavir: uncommon, 0.2%
- dasatinib: postmarketing, common, 0% - 2%
- deferiprone: postmarketing
- degarelix: 4% - 7%
- delamanid
- delavirdine
- demethyl
- deprenyl: frequent, 3%
- desflurane: 1%
- desipramine
- desmopressin: 2%
- desogestrel
- desvenlafaxine
- dexamethasone: 6.4% - 12.7%
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing, very common, 4% - 30%
- diatrizoate
- diazoxide
- diclofenac: very rare, postmarketing, 0% - 3%
- dicyclomine: postmarketing
- dihydroergotamine: postmarketing
- dipivefrin
- dipyridamole: 1.5%
- docetaxel: postmarketing, common, 1.6% - 2%
- dofetilide
- dolasetron: 2.19% - 2.88%
- donepezil: frequent, 3%
- dopamine
- dorzolamide
- dothiepin
- doxepin: 1% - 3%
- doxercalciferol
- doxorubicin: common
- doxycycline: 0% - 1.6%
- doxycycline hyclate
- droperidol
- duloxetine
- efavirenz
- eletriptan: infrequent
- entacapone
- ephedrine
- ergonovine
- ergotamine
- ertapenem
- eslicarbazepine: 1%
- eslicarbazepine acetate
- esomeprazole magnesium
- estradiol: 0% - 6.74%
- estramustine phosphate
- etodolac
- etomidate
- etoposide
- etoposide phosphate
- etoricoxib
- etravirine: 2.8%
- everolimus: common, very common, 0% - 47.4%
- exemestane: 1.7% - 15.1%
- exenatide: 1.21% - 3.14%
- ezetimibe
- febuxostat
- felbamate
- fenofibrate
- fenofibric acid
- fentanyl: very rare, postmarketing, 0% - 1%
- ferumoxytol: postmarketing, 1%
- flecainide
- fluconazole
- fludrocortisone
- fludrocortisone acetate
- flumazenil
- flunisolide
- fluorescein: very rare, postmarketing
- fluoxetine: frequent
- fluphenazine
- fluphenazine decanoate
- flurbiprofen
- flutamide
- fluticasone
- fluticasone propionate
- fluvastatin
- fluvoxamine: infrequent, frequent, 1% - 2%
- formoterol: postmarketing
- fosaprepitant dimeglumine: 2.1% - 3.2%
- foscarnet
- fosinopril: uncommon
- fosphenytoin: frequent
- gabapentin: infrequent, frequent
- gadobenate dimeglumine: postmarketing
- gadofosveset
- gadolinium
- gadopentetate
- gadoteridol: postmarketing
- gadoversetamide
- galantamine: postmarketing, frequent, 4%
- ganciclovir: 12% - 20%
- gatifloxacin
- gemcitabine
- gentamicin
- gliclazide: 3.2% - 3.7%
- glimepiride
- glipizide
- glucagon
- glucagon hydrochloride
- glucose
- glycopyrrolate
- granisetron: infrequent, common, 1% - 2.6%
- halcinonide
- haloperidol
- histamine
- hydromorphone
- hydroxybutyrate: postmarketing
- ibandronate: 5.3% - 7.3%
- ibuprofen: 0%
- ibutilide: 1.2%
- icodextrin: 8% - 13%
- ifosfamide: postmarketing, 1%
- imatinib: infrequent, uncommon
- imipramine
- imiquimod: 1.4%
- indomethacin
- insulin detemir: 0.8% - 1%
- iodixanol
- iohexol
- iopamidol
- iopromide: 0.1%
- ioversol
- ioxilan
- ipratropium bromide: 0.9% - 1.9%
- irbesartan: postmarketing
- irinotecan
- iron sucrose: 5.5% - 8%
- isomannide
- isopropyl unoprostone
- isoproterenol
- isosorbide-5-mononitrate
- itraconazole: 0% - 3%
- ketoprofen
- ketorolac: 2%
- ketorolac tromethamine: postmarketing
- ketotifen
- lamotrigine: rare, infrequent
- lanreotide
- lansoprazole
- leflunomide: 0% - 10%
- lenalidomide: postmarketing, uncommon, 6.08% - 7.93%
- letrozole: uncommon, 4% - 8%
- leuprorelin acetate
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- linezolid
- lisdexamfetamine dimesylate
- lomefloxacin
- loratadine
- lorazepam: 0.1%
- lorcaserin: 5.08%
- loxapine
- lurasidone: infrequent, frequent
- mannitol
- maprotiline
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 0% - 8%
- megestrol acetate
- melatonin
- meloxicam: 0% - 2.2%
- memantine: 3.98% - 4%
- meperidine
- mepivacaine
- meropenem
- mesna: postmarketing
- metaproterenol: 0.4% - 2%
- metformin
- methylene blue
- methylergometrine
- methylphenidate: 2.2%
- methylprednisolone
- methylprednisolone sodium succinate
- metipranolol
- metoclopramide: postmarketing
- metoprolol: common
- metronidazole: 0.529% - 1.08%
- metyrapone
- mexiletine
- mianserin
- midodrine: uncommon, common, 0% - 7.3%
- mifepristone: 24%
- milnacipran: 3% - 7%
- minocycline: 0.8% - 2.8%
- mipomersen: 7%
- mirabegron: 0.5% - 11.3%
- mirtazapine: postmarketing, frequent
- misoprostol: postmarketing
- mitomycin C
- mitotane
- mitoxantrone: 4%
- moclobemide
- modafinil: postmarketing
- morphine
- moxifloxacin
- mycophenolate mofetil: 2.8% - 77.5%
- mycophenolic acid: 18% - 77.5%
- nabilone
- nabumetone: postmarketing, 1.7%
- nalbuphine
- nalmefene: 5% - 7%
- naloxone
- naltrexone
- nandrolone decanoate
- naphazoline
- naproxen: postmarketing
- nefazodone: infrequent
- nepafenac
- nesiritide
- nicardipine: 0.7%
- nicorandil: common
- nicotine
- nilotinib: common
- nilutamide: 5.3%
- nimodipine
- nitazoxanide
- norepinephrine
- nortriptyline
- ofatumumab: 0% - 8%
- ofloxacin
- olanzapine: 0% - 3%
- olsalazine
- omeprazole
- oxaliplatin: rare, common
- oxaprozin
- oxcarbazepine: very rare
- oxybutynin: 1.3%
- oxymorphone
- paclitaxel: uncommon, 1%
- paliperidone
- palonosetron
- pamidronate: common, 0% - 6%
- pantoprazole
- parecoxib
- paricalcitol: 6.5% - 7%
- paroxetine: postmarketing, infrequent, common, frequent, 2%
- pazopanib: 0% - 42%
- pegaptanib
- pegaptanib sodium
- pemetrexed
- pentamidine
- pentazocine
- pentostatin
- pentoxifylline
- pergolide: frequent, 1.6%
- perphenazine
- phentermine
- phentolamine
- phenylephrine
- phenytoin: frequent
- pilocarpine: 3%
- pimozide
- pioglitazone: 0%
- piroxicam
- ponatinib: 26% - 71%
- posaconazole
- pramipexole
- prasugrel: 7.1% - 7.5%
- pravastatin: 0.7%
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin: frequent, 2.2%
- prilocaine
- procaine
- procarbazine
- progesterone: postmarketing
- propafenone
- propofol
- protriptyline
- quetiapine: 1% - 2%
- rabeprazole
- raltegravir
- rapamycin: very common, 23% - 49%
- rasagiline
- rasburicase
- reboxetine: postmarketing, 1.18%
- regadenoson: postmarketing, uncommon
- regorafenib
- remifentanil: 0% - 6.17%
- repaglinide
- rescinnamine: 1.4%
- retinoic acid: 11%
- ribavirin: common
- rifapentine
- riluzole: 3.3% - 6.8%
- rimantadine
- risedronate: 4.2% - 10.6%
- risperidone: postmarketing, infrequent, 1% - 3%
- ritonavir
- rivastigmine: very rare, postmarketing, common, 1% - 3%
- rizatriptan: infrequent
- rocuronium: 2%
- rofecoxib: 1.6% - 8.2%
- ropinirole: postmarketing, frequent, 3% - 5%
- ropivacaine: 0.5% - 8.3%
- rosiglitazone: 4.4% - 6.1%
- rotigotine: 3%
- salbutamol: postmarketing, 1% - 3.1%
- salmeterol: 4%
- salmon calcitonin acetate: postmarketing, uncommon
- samarium: 3.02%
- saquinavir
- sertraline: postmarketing, infrequent, uncommon
- sevelamer hydrochloride: 5.9% - 10.1%
- sevoflurane
- sibutramine
- sildenafil: postmarketing, rare
- sitagliptin
- sodium acetate
- sodium ferric gluconate: 0.6% - 23%
- sodium iothalamate
- solifenacin: 0.5% - 1.4%
- sorafenib: postmarketing, 1% - 17%
- sotalol: 1% - 2%
- sparfloxacin
- succinylcholine
- sufentanil: 3%
- sugammadex
- sulindac
- sumatriptan: infrequent, 1%
- sunitinib: 8%
- tacrolimus: very common, 0% - 91.1%
- tadalafil: postmarketing, 1% - 3%
- tamoxifen: 7-11% - 13%
- tamsulosin: 0.9%
- telavancin: uncommon
- telmisartan: 1%
- temozolomide: uncommon
- temsirolimus: 7%
- teniposide
- tesamorelin: 1.3% - 1.6%
- testosterone: postmarketing, uncommon, 0% - 3%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrofosmin
- thalidomide: 0% - 11.8%
- thiotepa
- tiagabine: frequent
- ticagrelor: 3.8% - 4%
- tigecycline: 4.9% - 5.6%
- timolol: postmarketing
- tiotropium
- tirofiban
- tizanidine
- tofacitinib: 1.6% - 2.3%
- tolcapone: infrequent
- topiramate: 1% - 3%
- tramadol: postmarketing, uncommon, 2.3% - 2.33%
- trametinib: 3% - 15%
- travoprost: rare, uncommon
- trazodone: 1.3% - 2.1%
- triamcinolone
- triamcinolone acetonide
- triazolam
- triiodothyronine
- trimipramine
- tropisetron: 0.568% - 5.69%
- trovafloxacin
- unoprostone
- v 1784: postmarketing, very common, 0% - 53%
- valdecoxib
- valganciclovir: 3% - 18%
- valproate
- vandetanib: 0.9% - 33%
- varenicline: frequent
- venlafaxine: common, 1.1% - 5%
- verapamil: postmarketing, 1.7%
- verteporfin: uncommon
- vinblastine
- vincristine
- vinflunine
- vinorelbine: postmarketing
- vitamin D2
- voriconazole: 0% - 1.94%
- zalcitabine
- zaleplon: infrequent
- ziprasidone: frequent, 0% - 3%
- zoledronic acid: uncommon, common, 5.1% - 12.7%
- zolmitriptan: infrequent
- zolpidem: infrequent
- zonisamide: infrequent
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|